399 related articles for article (PubMed ID: 33439315)
1. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
[TBL] [Abstract][Full Text] [Related]
2. MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study.
Li Y; Jin Y; Wang Y; Liu W; Jia W; Wang J
Cancer Imaging; 2024 May; 24(1):65. PubMed ID: 38773634
[TBL] [Abstract][Full Text] [Related]
3. Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.
Li Y; Lv X; Wang B; Xu Z; Wang Y; Gao S; Hou D
Eur J Radiol; 2022 Oct; 155():110499. PubMed ID: 36049410
[TBL] [Abstract][Full Text] [Related]
4. Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature.
Li Y; Lv X; Wang B; Xu Z; Wang Y; Sun M; Hou D
Acad Radiol; 2023 Sep; 30(9):1887-1895. PubMed ID: 36586758
[TBL] [Abstract][Full Text] [Related]
5. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma.
Huang Z; Tu X; Yu T; Zhan Z; Lin Q; Huang X
Clin Radiol; 2024 Feb; 79(2):e305-e316. PubMed ID: 38000953
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
[TBL] [Abstract][Full Text] [Related]
7. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
[TBL] [Abstract][Full Text] [Related]
8. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
[TBL] [Abstract][Full Text] [Related]
9. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients.
Ren M; Yang H; Lai Q; Shi D; Liu G; Shuang X; Su J; Xie L; Dong Y; Jiang X
Med Phys; 2021 Sep; 48(9):5142-5151. PubMed ID: 34318502
[TBL] [Abstract][Full Text] [Related]
10. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
11. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X
Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860
[TBL] [Abstract][Full Text] [Related]
12. Radiomic Signatures for Predicting
Zheng L; Xie H; Luo X; Yang Y; Zhang Y; Li Y; Yin S; Li H; Xie C
Front Oncol; 2022; 12():931812. PubMed ID: 35912248
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
[TBL] [Abstract][Full Text] [Related]
14. Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.
Fan Y; Wang X; Yang C; Chen H; Wang H; Wang X; Hou S; Wang L; Luo Y; Sha X; Yang H; Yu T; Jiang X
J Magn Reson Imaging; 2023 Dec; 58(6):1838-1847. PubMed ID: 37144750
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases.
Fan Y; Dong Y; Sun X; Wang H; Zhao P; Wang H; Jiang X
BMC Cancer; 2022 Aug; 22(1):889. PubMed ID: 35964032
[TBL] [Abstract][Full Text] [Related]
16. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
[TBL] [Abstract][Full Text] [Related]
17. Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study.
Cao R; Pang Z; Wang X; Du Z; Chen H; Liu J; Yue Z; Wang H; Luo Y; Jiang X
Phys Med Biol; 2022 Jun; 67(12):. PubMed ID: 35588722
[No Abstract] [Full Text] [Related]
18. Multisequence MRI-based radiomics signature as potential biomarkers for differentiating KRAS mutations in non-small cell lung cancer with brain metastases.
Lv X; Li Y; Wang B; Wang Y; Xu Z; Hou D
Eur J Radiol Open; 2024 Jun; 12():100548. PubMed ID: 38298532
[TBL] [Abstract][Full Text] [Related]
19. Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features.
Zhu H; Song Y; Huang Z; Zhang L; Chen Y; Tao G; She Y; Sun X; Yu H
Asia Pac J Clin Oncol; 2022 Dec; 18(6):586-594. PubMed ID: 35098682
[TBL] [Abstract][Full Text] [Related]
20. Value of radiomics model based on multi-parametric magnetic resonance imaging in predicting epidermal growth factor receptor mutation status in patients with lung adenocarcinoma.
Wang Y; Wan Q; Xia X; Hu J; Liao Y; Wang P; Peng Y; Liu H; Li X
J Thorac Dis; 2021 Jun; 13(6):3497-3508. PubMed ID: 34277045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
